Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis

Arthritis and Rheumatism

Volumn 42, Issue 5, 1999, Pages 981-988

  Mack, Matthias ^a,c   Brühl, Hilke ^a   Gruber, Rudi ^a   Jaeger, Christian ^a   Cihak, Josef ^a   Eiter, Viktoria ^a   Plachý, JIŘÍ ^b   Stangassinger, Manfred ^a   Uhlig, Katrin ^a   Schattenkirchner, Manfred ^a   Schlöndorff, Detlef ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c Medizinische Poliklinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; JOINT EFFUSION; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE;

ADOLESCENT; ADULT; ARTHRITIS; CD4-CD8 RATIO; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENOTYPE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; RECEPTORS, CCR5; SPONDYLITIS, ANKYLOSING; SYNOVIAL FLUID;

EID: 0345620774     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4     Document Type: Article

References (42)

1. Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997;387:713-7.
2. Gunn M, Tangemann K, Tam C, Cyster J, Rosen S, Williams L. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A 1998;95:258-63.
3. Gunn M, Ngo V, Ansel K, Ekland E, Cyster J, Williams L. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998;391:799-803.
4. Butcher EC. Leukocytes-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-6.
5. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76: 301-14.
6. Baggiolini M, Denwald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675-705.
7. Neote K, DiGregorio D, Mak J, Horuk R, Schall T. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993;72:415-25.
8. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerad NP, et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosiniphils. J Exp Med 1996;183: 2437-48.
9. Samson M, Labbe O, Mollerea C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996;35:3362-7.
10. Wu L, Paxton W, Kassam N, Ruffing N, Rottmann J, Sullivan N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185: 1681-91.
11. Samson M, Libert F, Doranz B, Rucker J, Liesnard C, Farber C, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996;382:722-5.
12. Dean M, Carrington M, Winkler C, Huttley G, Smith M, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
13. Gong W, Howard OM, Turpin JA, Grimm MC, Ueda H, Gray PW, et al. Monocytes chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J Biol Chem 1998;273:4289-92.
14. Badolato R, Oppenheim J. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum 1996;26:526-38.
15. Feldmann M, Brennan F, Maini R. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
16. Moreland L, Baumgartner S, Schiff M, Tindall E, Fleischmann R, Weaver A, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
17. Koch A, Kunke S, Harlow L, Mazarakis D, Haines G, Burdick M, et al. Macrophage inflammatory protein-1: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994;93:921-8.
18. Rathanaswami P, Hachicha M, Sadick M, Schall T, McColl S. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J Biol Chem 1993;268:5834-9.
19. Hosaka S, Akahoshi T, Wada C, Kondo H. Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol 1994;97:451-7.
20. Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 1991;87:463-9.
21. Cush JJ, Lipsky PE. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 1988;31:1230-8.
22. Palmer D. The anatomy of the rheumatoid lesion. Br Med Bull 1995;51:286-95.
23. Rottman J, Ganley K, Williams K, Wu L, Mackay C, Ringler D. Cellular localization of the chemokine receptor CCR5: correlation to cellular targets of HIV-1 infection. Am J Pathol 1997;151: 1341-51.
24. Qin S, Rottman J, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-54.
25. Dolhain RJEM, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AMM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1961-9.
26. Miossec P, van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum 1997;40:2105-15.
27. Quayle AJ, Chormorat QAJ, Miossec P, Kjeldsen-Kragh P, Forre O, Natvig JB. Rheumatoid inflammatory T cell clones express mostly Th1 but also Th2 and mixed (ThO-like) cytokine patterns. Scand J Immunol 1993;38:603-10.
28. Miltenburg AMM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992;35:603-10.
29. Yin Z, Braun J, Neure L, Wu P, Eggens U, Krause A, et al. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum 1997; 40:69-79.
30. Taub D, Conolon K, Lloyd A, Oppenheim J, Kelvin D. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1a and MIP-1β. Science 1993;260:355-8.
31. Bonecchi R, Blanchi Q, Bordignon P, Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 helper cells (This) and Th2s. J Exp Med 1998;187:129-34,
32. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005-7.
33. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998;391:344-5.
34. Sallusto F, Lening D, Mackay C, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-83.
35. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
36. Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, et al. AOP-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med 1998;187:1215-24.
37. Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997;276:276-9.
38. Pablos JL, Carreira PE, Serrano L, Santiago B, Balsa A, Vicario JL, et al. The homozygous Δ32 deletion of the CC chemokine receptor CCR5 gene protects against rheumatoid arthritis [abstract]. Arthritis Rheum 1997;40 Suppl 9:S157.
39. Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Freiesleben Sorensen S, et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 1998;25:1462-5.
40. Cooke SP, Forrest G, Venables PJW, Hajeer A. The Δ32 deletion of CCR5 receptor in rheumatoid arthritis. Arthritis Rheum 1998; 41:1135-6.
41. Sozzani S, Ghezzi S, Iannolo G, Luini W, Borsatti A, Polentarutti N, et al. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 1998;187:439-44.
42. Plater-Zyberk C, Hoogewerf A, Proudfoot A, Power C, Wells TNC. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997;57:117-20.